{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:12:48Z","timestamp":1782886368313,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/jp.2015.22","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T14:13:49Z","timestamp":1427984029000},"page":"656-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine"],"prefix":"10.1038","volume":"35","author":[{"given":"J B","family":"Bier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B A","family":"Bier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T A","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"issue":"18","key":"BFjp201522_CR1","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2012.3951","volume":"307","author":"SW Patrick","year":"2012","unstructured":"Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM . Neonatal abstinence syndrome and associated health care expenditures United States, 2000-2009. JAMA 2012; 307 (18): 1934\u20131940.","journal-title":"JAMA"},{"key":"BFjp201522_CR2","unstructured":"Coyle MG Unpublished data from presentation, \u201cDo newborns really care what drug their mother took?\u201d, Neonatal Abstinence Syndrome Statewide Improvement Project, Neonatal Quality Improvement Collaborative of Massachusetts: Westborough, MA, 13\/6\/13."},{"issue":"3Pt1","key":"BFjp201522_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ajog.2005.03.072","volume":"193","author":"JJ McCarthy","year":"2005","unstructured":"McCarthy JJ, Leamon MH, Parr MS, Anania B . High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol 2005; 193 (3Pt1): 606\u2013610.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"BFjp201522_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1360-0443.2003.00245.x","volume":"98","author":"SD Schindler","year":"2003","unstructured":"Schindler SD, Eder H, Ortner R, Rhrmeister K, Langer M, Fischer G . Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction 2003; 98 (1): 103\u2013110.","journal-title":"Addiction"},{"issue":"24","key":"BFjp201522_CR5","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","volume":"363","author":"HE Jones","year":"2010","unstructured":"Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O\u2019Grady KE, Selby P, Martin PR, Fischer G . Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363 (24): 2320\u20132331.","journal-title":"N Engl J Med"},{"issue":"Suppl.1","key":"BFjp201522_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1360-0443.2012.04040.x","volume":"107","author":"MG Coyle","year":"2012","unstructured":"Coyle MG, Salibury AL, Lester BM, Jones HE, Lin H, Graf-Rohrmeister K, Fischer G . Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Addiction 2012; 107 (Suppl.1): 63\u201373.","journal-title":"Addiction"},{"issue":"7","key":"BFjp201522_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/aje\/kwu190","volume":"180","author":"SB Brogly","year":"2014","unstructured":"Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P . Prenatal buprenorphine versus methadone explosure and neonatal coutcomes: systematic review and meta-analysis. Am J Epidemiol 2014; 180 (7): 673\u2013686.","journal-title":"Am J Epidemiol"},{"key":"BFjp201522_CR8","first-page":"1367","volume-title":"Primary Pediatric Care 2","author":"LP Finnegan","year":"1992","unstructured":"Finnegan LP, Kaltenbach K et al. Neonatal abstinence syndrome In: Hoekelman FA, Friedman SB, Nelson NM (eds). Primary Pediatric Care 2. Mosby: St Louis, MO, 1992; 1367\u20131378."},{"key":"BFjp201522_CR9","unstructured":"WHO Anthro for personal computers, version 3.2.2, 2011: Software for assessing growth and development of the world\u2019s children. Geneva: WHO 2010, http:\/\/www.who.int\/childgrowth\/software\/en\/."},{"key":"BFjp201522_CR10","first-page":"345","volume":"176","author":"BR Vohr","year":"1985","unstructured":"Vohr BR, Garcia-Coll C . Neurodevelopmental and school performance of very low birth weight infants: a seven-year longitudinal study. Pediatrics 1985; 176: 345\u2013350.","journal-title":"Pediatrics"},{"key":"BFjp201522_CR11","unstructured":"Bayley Scales of Infant Development. 2nd edn. Psychological Corporation: New York, NY, 1993."},{"key":"BFjp201522_CR12","volume-title":"Motor Assessment of the Developing Infant","author":"MC Piper","year":"1994","unstructured":"Piper MC, Darrah J . Motor Assessment of the Developing Infant. WB Saunders Company: Philadelphia, PA, 1994."},{"key":"BFjp201522_CR13","doi-asserted-by":"publisher","first-page":"Fa45","DOI":"10.1136\/archdischild.2011.300164.94","volume":"96","author":"D Shipton","year":"2011","unstructured":"Shipton D, Mactier H, Dryden C, Tappin D . Substitute methadone prescribing in pregnancy is associated with impaired fetal head growth. Arch Dis Child Fetal Neonatal Ed 2011; 96: Fa45.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"BFjp201522_CR14","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1651-2227.2008.00838.x","volume":"97","author":"T Hytinantti","year":"2008","unstructured":"Hytinantti T, Kahila H, Renlund M, Jarvenpaa A, Halmesmaki E, Kivitie-Kallio S . Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero. Acta Paediatr 2008; 97: 1040\u20131044.","journal-title":"Acta Paediatr"},{"key":"BFjp201522_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.drugalcdep.2012.07.001","volume":"127","author":"G Welle-Strand","year":"2013","unstructured":"Welle-Strand G, Skurtveit S, Jones H, Waal H, Bakstad B, Bjark\u00f8 L, Ravndal E . Neonatal outcomes following in utero exposure to methadone or buprenorphine: A National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Drug Alcohol Depend 2013; 127: 200\u2013206.","journal-title":"Drug Alcohol Depend"},{"key":"BFjp201522_CR16","first-page":"935631.1","volume":"2011","author":"A Lui","year":"2011","unstructured":"Lui A, Bjorkman T, Stewart C, Nanan R . Pharmacological treatment of neonatal opiate withdrawal: between the devil and the deep blue sea. Int J Pediatr 2011; 2011: 935631.1\u2013935631.5.","journal-title":"Int J Pediatr"},{"key":"BFjp201522_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.brainres.2008.01.020","volume":"1198","author":"LM Schrott","year":"2008","unstructured":"Schrott LM, Franklin LM, Serrano PA . Prenatal opiate exposure impairs radial arm maze performance and reduces levels of BDNF precursor following training. Brain Res 2008; 1198: 132\u2013140.","journal-title":"Brain Res"},{"issue":"3Pt1","key":"BFjp201522_CR18","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ajog.2005.03.072","volume":"193","author":"JJ McCarthy","year":"2005","unstructured":"McCarthy JJ, Leamon MH, Parr MS, Anania B . High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obst Gyn 2005; 193 (3Pt1): 606\u2013610.","journal-title":"Am J Obst Gyn"},{"key":"BFjp201522_CR19","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0022-3476(81)80830-X","volume":"98","author":"GS Wilson","year":"1981","unstructured":"Wilson GS, Desmond MM, Wlit RB . Follow-up of methadone-treated women and their infants: Health, development, and social implications. J Pediatr 1981; 98: 716\u2013722.","journal-title":"J Pediatr"},{"key":"BFjp201522_CR20","doi-asserted-by":"crossref","unstructured":"Kronstadt D . Complex developmental issues of prenatal drug exposure. Drug Exposed Infants 1 (1) 1991.","DOI":"10.2307\/1602613"},{"key":"BFjp201522_CR21","first-page":"271","volume":"6","author":"K Kaltenbach","year":"1984","unstructured":"Kaltenbach K, Finnegan L . Developmental outcome of children born to methadone maintained women: a review of longitudinal studies. Neurobehav Toxicol Teratol 1984; 6: 271\u2013275.","journal-title":"Neurobehav Toxicol Teratol"},{"issue":"9","key":"BFjp201522_CR22","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/adc.2007.132985","volume":"93","author":"L McGlone","year":"2008","unstructured":"McGlone L, Mactier H, Hamilton R, Bradnam MS, Boulton RG, Borland W, Hepburn M, McCulloch DL . Visual evoked potentials in infants exposed to methadone in utero. Arch Dis Child 2008; 93 (9): 784\u2013786.","journal-title":"Arch Dis Child"},{"key":"BFjp201522_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4088\/JCP.v65n0214","volume":"65","author":"TF Oberlander","year":"2004","unstructured":"Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W . Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65: 230\u2013237.","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jp201522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp201522","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp201522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T11:19:09Z","timestamp":1647602349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jp201522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFjp201522"],"URL":"https:\/\/doi.org\/10.1038\/jp.2015.22","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,2]]},"assertion":[{"value":"8 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}